← Back to Search

Breast cancer risk report for Breast Cancer

N/A

Waitlist Available

Led By Mara Schonberg, MD, MPH

Research Sponsored by Beth Israel Deaconess Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 24 months

Awards & highlights

Study Summary

This trial will test a new way of assessing and managing breast cancer risk in women in their 40s. The goal is to improve care by making better use of mammography screening and breast cancer prevention interventions.

Eligible Conditions

Breast Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Screening intentions

Secondary outcome measures

Attended genetic counseling

Date of mammogram(s) after intervention

Decisional conflict scale

+15 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Breast cancer risk reportExperimental Treatment1 Intervention

An individualized report will inform women of their 5-year breast cancer risk using BCRAT or Tice (when breast density is available from a past mammogram), whichever is higher, and the average 5-year risk for women their age. The report will present 5-year risk as a frequency and in a pictograph and it will describe what experts recommend in terms of mammography screening, breast cancer prevention medications, breast MRIs, and BRCA testing, for women in their 40s based on their risk.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor

836 Previous Clinical Trials

13,009,990 Total Patients Enrolled

47 Trials studying Breast Cancer

6,927 Patients Enrolled for Breast Cancer

Mara Schonberg, MD, MPHPrincipal InvestigatorBeth Israel Deaconess Medical Center

1 Previous Clinical Trials

157 Total Patients Enrolled

1 Trials studying Breast Cancer

157 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being accepted for this examination?

"Unfortunately, this investigation is no longer recruiting patients to take part. It was initially publicized on July 1st 2017 and had a final edit made on the 29th of July 2021. Despite this study having been concluded, there are still 2602 other studies that require volunteers at present."

Answered by AI

Is the eligibility for this trial restricted to individuals aged twenty and older?

"The specified age range for this medical trial is 40 to 49 years old."

Answered by AI

What criteria must an individual fulfill to be eligible for enrollment in this clinical trial?

"This medical trial is trying to recruit 338 participants, all of whom must be women between the ages of 40 and 49 with an existing diagnosis of breast cancer. In addition, they need to have a planned visit scheduled in the next 4-12 weeks at HealthCare Associates (HCA)."

Answered by AI

Recent research and studies

American Journal of Preventive MedicineJournal

A Pre-test–post-test Trial of a Breast Cancer Risk Report for Women in Their 40s

Schonberg, Mara A., Roger B. Davis, Maria C. Karamourtopoulos, Adlin Pinheiro, Scot B. Sternberg, Alicia R. Jacobson, Gianna M. Aliberti, et al.. 2020. “A Pre-test–post-test Trial of a Breast Cancer Risk Report for Women in Their 40s”. American Journal of Preventive Medicine. Elsevier BV. doi:10.1016/j.amepre.2020.04.014.

clinicaltrials.govStudy

Breast Cancer Risk Assessment in Women Aged 40-49

Mara Schonberg 2017. "Breast Cancer Risk Assessment in Women Aged 40-49". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03180086.